Mirabella Financial Services LLP Altimmune, Inc. Transaction History

Mirabella Financial Services LLP

  • $1.04 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$8.74 - $16.45 $135,172 - $254,415
15,466 New
15,466 $254,000
Q1 2021

May 17, 2021
SELL
$12.71 - $24.31 $173,872 - $332,560
-13,680 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$7.84 - $14.22 $13,735 - $24,913
-1,752 Reduced 11.35%
13,680 $154,000
Q3 2020

Nov 13, 2020
BUY
$9.93 - $33.26 $153,239 - $513,268
15,432 New
15,432 $204,000

Others Institutions Holding ALT

# of Institutions
208
Shares Held
39.5M
Call Options Held
1.94M
Put Options Held
1.38M
View Full List

About Altimmune, Inc.

ALT Quotes by TradingView
  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $315M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Mirabella Financial Services LLP Portfolio

Follow Mirabella Financial Services LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

News

Stay updated on Mirabella Financial Services LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email